VistaGen Therapeutics, Inc. (VTGN) Social Stream



VistaGen Therapeutics, Inc. (VTGN): $1.11

-0.03 (-2.63%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add VTGN to Watchlist
Sign Up

Industry: Biotech


Ranked

of 395

in industry

VistaGen Therapeutics Inc (VTGN) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering VistaGen Therapeutics Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 2 $8 $5 $6.5 $1.15 465.22%
2022-02-10 2 $8 $8 $8 $1.15 595.65%

The Trend in the Analyst Price Target


VTGN's average price target has moved up $1 over the prior 26 weeks.

VTGN reports an average of 158.25% for its upside potential over the past 44 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-25 2 6 5 5.67 2.04 177.94%
2021-06-05 4 9 5 6.50 2.41 169.71%
2021-06-13 4 9 5 6.50 2.80 132.14%
2021-06-26 5 9 5 6.50 2.65 145.28%
2021-07-10 5 9 5 6.75 3.10 117.74%

VTGN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The Trend in the Broker Recommendations


VTGN's average broker recommendation rating improved by 0.5 over the prior 39 weeks.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, VistaGen Therapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 193.01% of them.
  • In the context of all US stocks, VistaGen Therapeutics Inc's number of analysts covering the stock is greater than 9.42% of them.
  • In terms of how VistaGen Therapeutics Inc fares relative to all US stocks, note that its average analyst price target is greater than 10.98% of that group.
  • In the context of stocks in the small market cap category, VistaGen Therapeutics Inc's variance in analysts' estimates is lower than 37.33% of them.

Stocks similar to VistaGen Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are VSTM, VRNA, and VRCA.

Make investment decisions regarding VTGN using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5031 seconds.